Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 68
Filtrar
1.
J Neonatal Perinatal Med ; 17(1): 49-55, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38457157

RESUMEN

INTRODUCTION: Retinopathy of prematurity (ROP) is one of the main reasons of preventable childhood blindness. In the development of ROP, MicroRNAs may be effective in the balance of factors that inhibit and activate angiogenic factors. We aimed to determine the changes in the blood levels of miR-146a, miR-143, miR-210, miR-21, miR-126, miR-211, miR-221, miR-106 and let 7f and to investigate their association with ROP. We hypothesed that the level of these miRNAs changed significantly in ROP cases. MATERIALS AND METHODS: This observational study was conducted prospectively in preterm infants with ROP. Serum levels of 8 miRNAs were measured. The relationship between disease stage and progression with miRNA gene expression was analysed. Preterm infants without ROP were taken as the control group. RESULTS: 47 patients with ROP and 14 controls, were included in the study. In the ROP group, miR-210, miR-146a, miR-21 were statistically significantly lower. In the ROP group the expression level of miR-143 was insignificantly lower, miRNA-221 was insignificantly higher, and miR-106, miR-126 and let 7f were variable. CONCLUSION: It was observed that miR-210, miR-146a, miR-21 and miR-143 were significantly lower in patients with ROP compared to the control group. However, no association could be established between the type of miRNA and stage of ROP. These miRNAs may be used as adjunctive biomarkers for diagnosis of ROP.


Asunto(s)
MicroARNs , Retinopatía de la Prematuridad , Humanos , Lactante , Recién Nacido , Biomarcadores , Edad Gestacional , Recien Nacido Prematuro , MicroARNs/genética , Factores de Riesgo
2.
Allergy ; 79(3): 580-600, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38084472

RESUMEN

Diagnosing immediate drug hypersensitivity reactions (IDHRs) can pose a significant challenge and there is an urgent need for safe and reliable tests. Evidence has emerged that the basophil activation test (BAT), an in vitro assay that mirrors the in vivo response, can be a complementary test for many drugs. In this position paper, members of Task Force (TF) "Basophil activation test in the evaluation of Drug Hypersensitivity Reactions" from the European Academy of Allergy and Clinical Immunology (EAACI) present the data from a survey about the use and utility of BAT in IDHRs in Europe. The survey results indicate that there is a great interest for using BAT especially for diagnosing IDHRs. However, there are still main needs, mainly in the standardization of the protocols. Subsequently consensus-based recommendations were formulated for: (i) Technical aspects of BAT in IDHRs including type of sample, management of drugs, flow cytometry protocols, interpretation of the results; and (ii) Drug-specific aspects that should be taken into account when performing BAT in relation to betalactams, neuromuscular blocking agents, fluoroquinolones, chlorhexidine, opioids, radio contrast media, chemotherapeutics, biological agents, nonsteroidal anti-inflammatory drugs, COVID vaccine, and excipients. Moreover, aspects in the evaluation of pediatric population have also been considered. All this indicates that BAT offers the clinician and laboratory a complementary tool for a safe diagnostic for IDHRs, although its place in the diagnostic algorithm depends on the drug class and patient population (phenotype, geography, and age). The standardization of BAT is important for generalizing this method beyond the individual laboratory.


Asunto(s)
Hipersensibilidad a las Drogas , Hipersensibilidad Inmediata , Hipersensibilidad , Humanos , Niño , Prueba de Desgranulación de los Basófilos/métodos , Basófilos , Vacunas contra la COVID-19 , Hipersensibilidad a las Drogas/diagnóstico
3.
Soc Psychiatry Psychiatr Epidemiol ; 58(6): 919-929, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36526939

RESUMEN

PURPOSE: The aim of this study is to evaluate the prevalence of anxiety disorders, its correlation with sociodemographic characteristics, its comorbidities with other psychiatric disorders and its predictors in school-aged children. METHODS: This study is part of a representative, multi-centered national study that is planned by the Turkish Association of Child and Adolescent Mental Health to evaluate the prevalence of psychopathology among elementary school students in Turkey between the years 2014-2015. Children are screened via Kiddie Schedule for Affective Disorders and Schizophrenia for School Age Children Present and Lifetime Version. Impairment is assessed by a 3-point Likert type scale independently by the parent and the teacher. The final sample included 5842 children with the mean age of 8.7 years. RESULTS: The prevalence of any anxiety disorder without considering impairment is 16.7% and considering impairment is 5.2% in children according to our study. We found significant differences for comorbid Attention Deficit Hyperactivity Disorder, Disruptive Behavior Disorder, Mood Disorders, Tic Disorders, Obsessive Compulsive Disorder, Enuresis Nocturna, Encopresis, and Intellectual Disability. Having a history of paternal physical disorder, living in the regions of Marmara, Mediterranean and Black Sea were found to be the main predictors of having childhood anxiety disorders according to the logistic regression analysis. CONCLUSION: Better understanding of childhood anxiety disorders, comorbid conditions and predictors will result in earlier diagnosis and more appropriate treatment.


Asunto(s)
Trastornos de Ansiedad , Trastorno por Déficit de Atención con Hiperactividad , Niño , Adolescente , Humanos , Prevalencia , Turquía/epidemiología , Trastornos de Ansiedad/psicología , Trastornos del Humor/epidemiología , Comorbilidad , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno por Déficit de Atención con Hiperactividad/epidemiología , Trastorno por Déficit de Atención con Hiperactividad/psicología , Estudios Epidemiológicos
4.
Hum Exp Toxicol ; 39(4): 423-432, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31789064

RESUMEN

Galectin-1 is an important mediator that regulates the T-cell-mediated immune response. It has many other biological functions such as cell growth, immunomodulation, and wound healing. The aim of this study was to reveal the role of galectin-1 on liver morphology, cell proliferation, apoptosis, inflammatory and anti-inflammatory mediators, oxidative stress, and antioxidant system in colitis-mediated hepatotoxicity induced by dextran sulfate sodium (DSS). In the present study, adult mice were divided into four groups: The control group intraperitoneally injected with phosphate buffer saline (I), the group which was orally administered with DSS (II), the control group which was injected with galectin-1 (III), and the group which was given DSS and galectin-1 (IV). DSS administration caused degenerative changes and diffuse necrotic damage, an increase in caspase-3 and cyclooxygenase-2 expression, the levels of lipid peroxidation and tumor necrosis factor-alpha, lactate dehydrogenase, and myeloperoxidase activities, and a decrease in cell proliferation, interleukin-10 levels, and antioxidant system parameters in liver tissues. Treatment of DSS group with galectin-1 reversed these effects and prevented liver damage. This study showed that galectin-1 has proliferative, antiapoptotic, anti-inflammatory, and antioxidant effects against DSS-induced liver injury in mice. It is expected considering all results of this study that galectin-1 may be useful as a protective agent against liver toxicity.


Asunto(s)
Apoptosis/efectos de los fármacos , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Galectina 1/farmacología , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Sustancias Protectoras/farmacología , Animales , Apoptosis/inmunología , Caspasa 3/genética , Proliferación Celular/efectos de los fármacos , Enfermedad Hepática Inducida por Sustancias y Drogas/enzimología , Enfermedad Hepática Inducida por Sustancias y Drogas/inmunología , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Colitis Ulcerosa/complicaciones , Ciclooxigenasa 2/genética , Citocinas/metabolismo , Sulfato de Dextran/toxicidad , Modelos Animales de Enfermedad , Inyecciones Intraperitoneales , Hígado/enzimología , Hígado/patología , Ratones Endogámicos C57BL , Estrés Oxidativo/genética , Estrés Oxidativo/inmunología , Proteínas Recombinantes/farmacología
5.
Niger J Clin Pract ; 22(6): 849-854, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31187772

RESUMEN

AIM: This study was planned and carried out to determine how teamwork attitudes of nurses working in surgical clinics affect their caring behaviors. MATERIALS AND METHODS: The research was conducted as a relational descriptive study. The research population consisted of 126 nurses working in the surgical clinics of a state hospital. A total of 116 nurses who agreed to participate in the study were admitted to the study. Data were collected using the Descriptive Characteristics Question Form, the Teamwork Attitudes Questionnaire (TAQ), and the Caring Behaviors Inventory-24 (CBI-24). Data were analyzed using counts, percentage distributions, Mann-Whitney U test, and Kruskal-Wallis tests, Games-Howell post hoc test, and Spearman's correlation. RESULTS: The nurses participating in the study were found to have a mean score of 112.11 ± 17.86 for the TAQ and a mean score of 4.95 ± 0.54 for the CBI. There was a statistically positive correlation between the nurses' teamwork attitudes and caring behaviors (P < 0.05). CONCLUSION: It can be said that the teamwork attitudes of the nurses had a positive effect on their caring behaviors. It may be suggested to plan relevant research studies examining especially observational behavioral assessments.


Asunto(s)
Actitud del Personal de Salud , Conducta , Enfermeras y Enfermeros/psicología , Atención de Enfermería , Adulto , Femenino , Conocimientos, Actitudes y Práctica en Salud , Hospitales Provinciales , Humanos , Masculino , Grupo de Atención al Paciente , Centros Quirúrgicos , Encuestas y Cuestionarios , Adulto Joven
6.
Eur J Neurol ; 26(1): 100-105, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30102816

RESUMEN

BACKGROUND AND PURPOSE: Hemodialysis (HD) may have some adverse effects on the nervous system. Headache is the most commonly reported neurological symptom amongst HD patients. Our aim was to determine the frequency, clinical characteristics and triggering factors of HD-related headache (HRH) and to evaluate preventive strategies for reducing HRH. METHOD: In all, 494 patients were included. Comparative controls (CC) were classified within the same patients without headache. Arterial systolic/diastolic blood pressure, blood urea nitrogen (BUN) and creatinine were correlated before/after one HD. The urea reduction ratio during the dialysis session was determined. RESULTS: A total of 175 patients (35.4%) with a mean age of 57.3 ± 15.7 years were diagnosed with HRH. HRH was more common in males (P < 0.001). Headache was started a mean of 2.90 ± 0.86 h after the HD. The common localization of pain was reported to be bifrontal in 41.7% (n = 73). The mean duration of headache was 6.22 ± 7.8 h, with a duration of ≤4 h reported by 64.0% of patients. The mean Visual Analog Scale score was 5.64 ± 2.05. The differences between pre/post-dialysis BUN values were 94.6 ± 31.1 in HRH patients and 86.8 ± 28.5 in the CC group (P = 0.006). The systolic blood pressure difference between the pre/post-dialysis measurements was 22.4 ± 16.5 mmHg in HRH patients and 12.8 ± 19.4 mmHg in CC(P < 0.001). Patients with HRH had significantly higher mean systolic and diastolic blood pressure pre-dialysis values (systolic, P = 0.002; diastolic, P < 0.001). The differences in systolic/diastolic blood pressure between pre/post-dialysis were higher in the HRH group (P < 0.001, P = 0.001, respectively). CONCLUSION: Regulating the frequency and timing of dialysis may provide better management in HRH with high BUN levels and high pre-dialysis blood pressure.


Asunto(s)
Cefalea/etiología , Cefalea/prevención & control , Diálisis Renal/efectos adversos , Adulto , Anciano , Presión Sanguínea , Nitrógeno de la Urea Sanguínea , Femenino , Humanos , Hipertensión/diagnóstico , Hipertensión/etiología , Masculino , Persona de Mediana Edad , Dimensión del Dolor
7.
Eur Ann Allergy Clin Immunol ; 50(2): 66-71, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29384109

RESUMEN

Summary: Objective. To document the test results of patients referred to our clinic for testing with local anesthetics (LAs) in real life conditions and provide data related to the necessity of these tests. Methods. All consecutive subjects who were referred to be evaluated for LA allergy during a two-year follow up were included in the analysis. All subjects underwent skin prick / intradermal tests followed by a subcutaneous provocation test with the LAs tested. Results. A total of 228 subjects were included. The main referral reason was the presence of a history of drug hypersensitivity reaction (DHR) to drugs other than LAs (n = 128; 56%), whereas a history of LA allergy constituted the second most common referral reason (n = 64, 28.1%). In the majority of cases (n = 39; 60.9%), the culprit LA was not known by the patients. Asthma was the third most common referral reason, presented in 49 cases (21.5%). Ten cases had positivity to the tested LA in skin testing / challenges. Nine out of 10 patients had a history of DHR to drugs other than LA, whereas 5 of them had also a history of DHR to LA. Six of the 10 patients had a history of multiple DHR. None of the asthma patients without any DHR history were positive in the LA tests. Eight out of 10 cases who underwent skin testing / challenge with an alternative LA, tolerated the alternative LA. Conclusion. The most common referral reason for testing with LA was a history of DHR to drugs other than LAs, whereas asthma was the third most common referral reason. Patients with a history of multiple DHR may be considered for testing with LAs. Asthmatics and those with other allergic diseases without a history of drug / LA allergy do not need to be tested with LA.


Asunto(s)
Anestésicos Locales/inmunología , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/inmunología , Hipersensibilidad Inmediata/diagnóstico , Adolescente , Adulto , Anestésicos Locales/efectos adversos , Asma/inducido químicamente , Asma/patología , Femenino , Humanos , Hipersensibilidad Inmediata/inducido químicamente , Hipersensibilidad Inmediata/patología , Lidocaína/inmunología , Masculino , Mepivacaína/inmunología , Persona de Mediana Edad , Prilocaína/inmunología , Estudios Prospectivos , Pruebas Cutáneas , Adulto Joven
8.
Eur Ann Allergy Clin Immunol ; 50(1): 36-41, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29350020

RESUMEN

Summary: Background and objective. Many studies have shown associations between HLAB*15:02, HLA-A*31:01 and carbamazepine (CBZ)-induced delayed cutaneous hypersensitivity reactions. The aim of this study is to evaluate a possible association between delayed cutaneous reactions to antiepileptic drugs (AEDs) and certain HLA-A and HLA-B alleles in the Turkish population. Methods. The study consisted of 3 groups: Group I (reactive group) included the patients who had documented delayed cutaneous reactions to any antiepileptic drug. Group II (non-reactive group) included the patients who have been on antiepileptic treatment at least for three months without any adverse reactions. Group III consisted of healthy subjects. The HLA-A and B alleles were analyzed in all groups. Results. Forty patients (29 female) had experienced different hypersensitivity reactions due to AEDs: maculopapular exanthema (26 patients), Stevens-Johnson syndrome (6 patients), drug rash with eosinophilia and systemic symptoms (7 patients), toxic epidermal necrolysis (1 patient). Lamotrigine (11) and CBZ (10) were the most common culprit drugs involved in the reactions. The HLA-B*15:02 was not present in any of the study groups. However, HLA-B*35:02 was found in 4 patients from the reactive group, while it was not observed in non-reactive patients and was detected in only one healthy subject (p = 0.021). Conclusion. Although our preliminary results did not indicate a strong allele association with AED hypersensitivity, HLA-B*35:02 appears to be a candidate allele for MPE / DRESS / DIHSS induced by AED's in Turkish population. Further studies with a larger sample size may result in more comprehensive data about the genetic tendency for AED hypersensitivity in the Turkish population.


Asunto(s)
Hipersensibilidad a las Drogas/genética , Genotipo , Antígenos HLA-A/genética , Antígenos HLA-B/genética , Hipersensibilidad Tardía/genética , Adolescente , Adulto , Anciano , Alelos , Alérgenos/inmunología , Anticonvulsivantes/inmunología , Anticonvulsivantes/uso terapéutico , Carbamazepina/inmunología , Carbamazepina/uso terapéutico , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Genético , Turquía , Adulto Joven
9.
Clin Transl Allergy ; 7: 7, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28293415

RESUMEN

Drug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in both ambulatory and hospital settings and have a complex diagnosis that requires a detailed clinical history and other tests that may include in vitro tests and in vivo procedures such as skin tests and drug provocation tests. Although over the years both European and U.S. experts have published statements on general procedures for evaluating DHRs, a substantial discordance in their daily management exists. In this review, we highlight both the differences and the similarities between the European and U.S. PERSPECTIVES: While a general consensus exists on the importance of skin tests for evaluating DHRs, concordance between Americans and Europeans exists solely regarding their use in immediate reactions and the fact that a confirmation of a presumptive diagnosis by drug provocation tests is often the only reliable way to establish a diagnosis. Finally, great heterogeneity exists in the application of in vitro tests, which require further study to be well validated.

10.
Transplant Proc ; 49(3): 436-439, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28340807

RESUMEN

Viral infections lead to significant morbidity and mortality in kidney transplant recipients. We evaluated 49 kidney transplant recipients for human herpesvirus 8 (HHV-8) and BK polyomavirus infections in conjunction with data obtained from 43 donors. The seroprevalence of HHV-8 was 6.9% in donors and 12.2% in recipients. HHV-8 DNA was detected below the limit of quantification (<5000 copies/mL) in a recipient with HHV-8 seropositivity at the pretransplant period and was undetectable at month 3 after transplantation. Transient viruria with BK polyomavirus was recorded in 10.2% of recipients without viremia. Multiple factors contribute to viral reactivation, particularly immunosuppressive treatment. Reduction in maintenance immunosuppression seems beneficial in terms of viral reactivation. At our center, routine use of valganciclovir for antiviral prophylaxis may be effective for the prevention of HHV-8 reactivation.


Asunto(s)
Infecciones por Herpesviridae/epidemiología , Herpesvirus Humano 8 , Fallo Renal Crónico/virología , Trasplante de Riñón , Infecciones por Polyomavirus/epidemiología , Virus BK/genética , Humanos , Fallo Renal Crónico/cirugía , Prevalencia , Estudios Seroepidemiológicos
11.
Eur J Trauma Emerg Surg ; 43(6): 863-868, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27709248

RESUMEN

PURPOSE: We aimed to compare two digital nerve block techniques in patients due to traumatic digital lacerations. METHODS: This was a randomized-controlled study designed prospectively in the emergency department of a university-based training and research hospital. Randomization was achieved by sealed envelopes. Half of the patients were randomised to traditional (two-injection) digital nerve block technique while single-injection digital nerve block technique was applied to the other half. Score of pain due to anesthetic infiltration and suturing, onset time of total anesthesia, need for an additional rescue injection were the parameters evaluated with both groups. Epinephrin added lidocaine hydrochloride preparation was used for the anesthetic application. Visual analog scale was used for the evaluation of pain scores. Outcomes were compared by using Mann-Whitney U test and Student t-test. RESULTS: Fifty emergency department patients ≥18 years requiring digital nerve block were enrolled in the study. Mean age of the patients was 33 (min-max: 19-86) and 39 (78 %) were male. No statistically significant difference was found between the two groups in terms of our main parameters; anesthesia pain score, suturing pain score, onset time of total anesthesia and rescue injection need. CONCLUSION: Single injection volar digital nerve block technique is a suitable alternative for digital anesthesias in emergency departments.


Asunto(s)
Anestésicos Locales/uso terapéutico , Traumatismos de los Dedos/cirugía , Lidocaína/uso terapéutico , Bloqueo Nervioso , Heridas Penetrantes/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Anestésicos Locales/administración & dosificación , Esquema de Medicación , Servicio de Urgencia en Hospital , Femenino , Hospitales Universitarios , Humanos , Inyecciones Subcutáneas , Laceraciones/cirugía , Lidocaína/administración & dosificación , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Estudios Prospectivos , Resultado del Tratamiento , Adulto Joven
12.
Allergy ; 71(11): 1533-1539, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27145347

RESUMEN

The strongest and best-documented risk factor for drug hypersensitivity (DH) is the history of a previous reaction. Accidental exposures to drugs may lead to severe or even fatal reactions in sensitized patients. Preventable prescription errors are common. They are often due to inadequate medical history or poor risk assessment of recurrence of drug reaction. Proper documentation is essential information for the doctor to make sound therapeutic decision. The European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well as general guidelines of drug allergy documentation. A drug allergy passport, a drug allergy alert card, a certificate, and a discharge letter after medical evaluation are adequate means to document DH in a patient. They are to be handed to the patient who is advised to carry the documentation at all times especially when away from home. A drug allergy passport should at least contain information on the culprit drug(s) including international nonproprietary name, clinical manifestations including severity, diagnostic measures, potential cross-reactivity, alternative drugs to prescribe, and where more detailed information can be obtained from the issuer. It should be given to patients only after full allergy workup. In the future, electronic prescription systems with alert functions will become more common and should include the same information as in paper-based documentation.


Asunto(s)
Documentación , Hipersensibilidad a las Drogas/diagnóstico , Tarjetas Inteligentes de Salud , Documentación/métodos , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/prevención & control , Europa (Continente) , Humanos , Encuestas y Cuestionarios
13.
Allergy ; 71(8): 1103-34, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-26991315

RESUMEN

Drug hypersensitivity reactions (DHRs) are a matter of great concern, both for outpatient and in hospital care. The evaluation of these patients is complex, because in vivo tests have a suboptimal sensitivity and can be time-consuming, expensive and potentially risky, especially drug provocation tests. There are several currently available in vitro methods that can be classified into two main groups: those that help to characterize the active phase of the reaction and those that help to identify the culprit drug. The utility of these in vitro methods depends on the mechanisms involved, meaning that they cannot be used for the evaluation of all types of DHRs. Moreover, their effectiveness has not been defined by a consensus agreement between experts in the field. Thus, the European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology has organized a task force to provide data and recommendations regarding the available in vitro methods for DHR diagnosis. We have found that although there are many in vitro tests, few of them can be given a recommendation of grade B or above mainly because there is a lack of well-controlled studies, most information comes from small studies with few subjects and results are not always confirmed in later studies. Therefore, it is necessary to validate the currently available in vitro tests in a large series of well-characterized patients with DHR and to develop new tests for diagnosis.


Asunto(s)
Hipersensibilidad a las Drogas/diagnóstico , Pruebas Cutáneas/métodos , Biomarcadores , Hipersensibilidad a las Drogas/sangre , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/genética , Antígenos HLA/genética , Antígenos HLA/inmunología , Humanos , Inmunidad , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Técnicas In Vitro , Guías de Práctica Clínica como Asunto , Linfocitos T/inmunología , Linfocitos T/metabolismo
14.
Minerva Pediatr ; 67(1): 19-24, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25602748

RESUMEN

AIM: The aim of this study was to determine the prevalence of norovirus among children with acute gastroenteritis in 2009 and 2010. We also aimed that, to detecting the possible clinical and laboratory differences among cases in 2009 and 2010. METHODS: Fecal samples were collected from children under 16 years of age who were admitted for acute gastroenteritis. Norovirus was detected using immunochromatography. For the comparison of seasonal distribution, clinical manifestations, and laboratory results between cases, we divided subjects into two groups by year. RESULTS: Norovirus infection was detected in 112 of the 1027 collected samples (10.9%). In three cases with norovirus, other enteric viruses like rotavirus and adenovirus are detected concurrently, and these were excluded. After the exclusion of three cases with co-infections, statistical analysis was made in 109 cases. Most of the positive cases were between 1-24 months of age (N.=75, 67%). The rate of norovirus infection peaked in winter in 2010 (P<0.05). However, the rates were not significantly different between seasons in 2009 (P>0.05). We did not detect any positive cases in late summer and autumn in 2010. Diarrhea (97.2%), vomiting (95.4%), and abdominal pain (65.1%) were most frequently encountered symptoms of patients with norovirus. Leukocytosis and neutrophilia were significantly higher in 2010 than 2009 (P<0.05). CONCLUSION: The prevalence and clinical characteristics of norovirus in our study group is similar but seasonal distribution is different between two years. Most of the cases were <24 months of age. Like rotavirus, norovirus vaccine can be developed to prevent infection.


Asunto(s)
Infecciones por Caliciviridae/epidemiología , Gastroenteritis/epidemiología , Norovirus/aislamiento & purificación , Dolor Abdominal/epidemiología , Dolor Abdominal/virología , Enfermedad Aguda , Distribución por Edad , Infecciones por Caliciviridae/virología , Niño , Preescolar , Diarrea/epidemiología , Diarrea/virología , Gastroenteritis/virología , Hospitalización , Humanos , Lactante , Recién Nacido , Prevalencia , Estudios Retrospectivos , Estaciones del Año , Vómitos/epidemiología , Vómitos/virología
15.
J Obstet Gynaecol ; 35(6): 561-4, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25409325

RESUMEN

More than half of pregnant women suffer from nausea and vomiting, in 0.5-1% of the pregnant women, if nausea and vomiting are severe and persistent, condition can progress to hyperemesis. We evaluated the fluid volume parameters in pregnant women with hyperemesis gravidarum, before and after treatment using the bioelectrical impedance vectors. A total of 70 pregnant women who had weight loss exceeding 5% of pre-pregnancy body weight were recruited for the study in the first trimester. The measurement of multi-frequency bioelectrical impedance analysis parameters was performed on the day of hospitalisation before any treatment and after treatment at 24 h and 72 h with the same procedure. Total body water, extracellular water, intracellular water, and fat-free mass index increased after treatment at 24 h (P < 0.01). Also, the mean pregnancy-unique quantification of emesis and nausea score was significantly lower after treatment (11.3 ± 2.1 at enrolment, 5.1 ± 1.4 at 24 h and 4.3 ± 1.1 at 72 h) (P < 0.01), which correlated with the patients' clinical improvement and changes in hydration. In pregnant women with moderate-to-severe hyperemesis gravidarum, significant body composition changes occur and fluid replacement therapy performed during a short period of time, such as 24 h, provides improvement in body composition.


Asunto(s)
Composición Corporal , Impedancia Eléctrica , Hiperemesis Gravídica/fisiopatología , Hiperemesis Gravídica/terapia , Adulto , Agua Corporal , Líquido Extracelular , Femenino , Fluidoterapia , Humanos , Líquido Intracelular , Embarazo , Primer Trimestre del Embarazo , Pérdida de Peso
16.
Hum Exp Toxicol ; 34(3): 324-9, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24972621

RESUMEN

INTRODUCTION: Accidental carbon monoxide (CO) intoxication is a major cause of unintentional poisoning. This study aimed to determine the value of initial lactate levels in patients with CO poisoning and to evaluate its utilization in the emergency department (ED). METHODS: A retrospective cross-sectional study was carried out among patients with CO intoxication, who were admitted to the ED between April 1, 2011 and April 1, 2012. The study data were extracted from a hospital database system using International Classification of Diseases-10 diagnosis codes. The patients were analyzed according to lactate levels, carboxyhemoglobin (COHb) levels, electrocardiographic manifestations, and clinical features at admission to the ED. RESULTS: A total of 74 patients with CO poisoning were enrolled in this study. The average COHb value of the patients was 21.5 ± 13.9%. A total of 50 patients (67.6%) received normobaric oxygen treatment and 24 patients (32.4%) received hyperbaric oxygen (HBO) treatment. The patients who received HBO treatment had increased lactate levels compared with patients receiving normobaric oxygen treatment (2.3 mmol/L vs. 1.0 mmol/L, p < 0.001). The lactate levels were positively correlated with COHb values (r = 0.738, p < 0.001). We determined that a lactate level of 1.85 mmol/L has a sensitivity of 70.8% and a specificity of 78.0% to predict the HBO treatment needed in CO poisoning. CONCLUSION: In evaluating patients with CO poisoning, an initial lactate level could be taken into consideration as an adjunctive parameter of severity, together with the clinical criteria and levels of COHb.


Asunto(s)
Intoxicación por Monóxido de Carbono/sangre , Lactatos/sangre , Adolescente , Adulto , Intoxicación por Monóxido de Carbono/terapia , Carboxihemoglobina/análisis , Estudios Transversales , Femenino , Humanos , Masculino , Terapia por Inhalación de Oxígeno , Estudios Retrospectivos , Adulto Joven
17.
Eye (Lond) ; 28(12): 1477-81, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25257772

RESUMEN

PURPOSE: The purpose of this study was to assess choroidal thickness in migraine patients during acute migraine attacks and compare them with healthy controls, using spectral domain optical coherence tomography (OCT). PATIENTS AND METHODS: In this prospective case-control study, choroidal thicknesses of 46 migraine patients during acute migraine attacks and 46 age- and sex-matched healthy subjects were measured using a high-speed, high-resolution frequency domain-OCT device. All patients underwent a complete ophthalmic examination before the measurements. OCT measurements were taken at the same time of day (0900 hours), in order to minimize the effects of diurnal variation. RESULTS: There was a statistically significant difference in mean choroidal thickness between the migraine patients during acute migraine attacks (356.3±21.46 µm) and the controls (302.3±18.34 µm; P=0.000). There were significant differences at all measurement points (P<0.001 for all). CONCLUSION: The increased choroidal thickness of the migraine patients during acute migraine attacks might be related to the vascular pathology of the disease. Further studies are needed to evaluate the etiopathologic relationship between choroidal thickness and acute migraine attack.


Asunto(s)
Coroides/patología , Trastornos Migrañosos/complicaciones , Enfermedad Aguda , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Estudios Prospectivos , Tomografía de Coherencia Óptica
18.
Allergol. immunopatol ; 42(2): 115-119, mar.-abr. 2014. tab, graf
Artículo en Inglés | IBECS | ID: ibc-121009

RESUMEN

BACKGROUND-OBJECTIVE: Several factors might affect the adherence to treatment in patients with asthma and COPD. Among these factors, the effect of religious beliefs and behaviours has been less studied so far. In this study, the effect of fasting on drug use behaviours of patients with asthma and COPD were comparatively analysed. METHODS: A total of 150 adult patients with asthma and 150 adult patients with COPD were consecutively enrolled into this cross-sectional study. The patients were asked whether they fast during Ramadan and if the answer was yes, they were kindly asked to respond to further questions related to use of inhaled medications during that particular time. RESULTS: The majority of the cases from both groups [98 (65.3%) of asthma patients and 139 (92.6%) of COPD] were fasting during Ramadan. The majority of the patients with COPD (n = 126; 90.6%) reported that they quitted their regular therapy basis during Ramadan. On the other hand, the majority of asthma patients used their controller inhaled medications during Ramadan and preferred to use them on iftar and sahur times (n = 81, 82.6%). CONCLUSION: Our results showed that in a Muslim population, the patients with asthma and COPD do not feel their diseases to be an inhibitory factor for fasting during Ramadan. However, fasting seems to be an important determining factor in medication compliance by modifying the drug use behaviours in each group in a different way. Therefore, the patients should be informed about the effects of fasting on their disease and the allowed drugs during fasting


No disponible


Asunto(s)
Humanos , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Asma/tratamiento farmacológico , Cumplimiento de la Medicación , Religión y Medicina , Ayuno
19.
Allergol Immunopathol (Madr) ; 42(6): 573-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24269184

RESUMEN

BACKGROUND: No data are available on the incidence of drug hypersensitivity (DH) reactions in outpatient settings of tertiary allergy/immunology clinics. Our aims were to document the frequency of outpatient hospital admissions due to DH reactions to allergy/immunology clinics in adults and the management of these reactions in real life. We also investigated whether drug allergy affected social and medical behaviours of the patients. METHODS: This multi-centre study was performed for one year with the participation of 11 out of 16 tertiary allergy/clinical immunology clinics in Turkey. The study group consisted of the patients with DH reactions. Results of a questionnaire including drug reactions and management were recorded. RESULTS: Among 54,863 patients, 1000 patients with DH were enrolled with a median of 2.1% of all admissions. In real life conditions, the majority of approaches were performed for finding safe alternatives (65.5%; 1102 out of 1683) with 11.7% positivity. Diagnostic procedures were positive in 27% (154/581) of the patients. The majority of the patients had higher VAS scores for anxiety. A total of 250 subjects (25%) reported that they delayed some medical procedures because of DH. CONCLUSION: Our results documented the frequency of admissions due to DH reactions to allergy/clinical immunology clinics for the first time. Although physicians mostly preferred to perform drug tests in order to find safe alternatives, considering the fact that DH was confirmed in 27% of the patients, use of diagnostic tests should be encouraged, if no contraindication exists in order to avoid mislabelling patients as DH.


Asunto(s)
Trastornos de Ansiedad/epidemiología , Hipersensibilidad a las Drogas/epidemiología , Hospitales Especializados/estadística & datos numéricos , Admisión del Paciente/estadística & datos numéricos , Atención Terciaria de Salud/estadística & datos numéricos , Administración Oral , Adulto , Alérgenos/efectos adversos , Alérgenos/inmunología , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/uso terapéutico , Hipersensibilidad a las Drogas/diagnóstico , Femenino , Humanos , Inmunización , Masculino , Percepción , Turquía , beta-Lactamas/efectos adversos , beta-Lactamas/uso terapéutico
20.
Scand J Rheumatol ; 43(1): 63-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24015673

RESUMEN

OBJECTIVES: Behçet's disease (BD) is a systemic vasculitis involving diverse sizes of arteries and veins. The aim of this study was to evaluate the relationship between central blood pressures, pulse wave velocity (PWV) measurements, and biochemical parameters in patients with inactive and active BD and control subjects. METHOD: Ninety-six patients with BD were recruited in this study. Each subject was evaluated in active and inactive disease periods. For the control group, 54 healthy age- and sex-matched subjects were enrolled. All patients completed a standard questionnaire form and various laboratory parameters were evaluated. Vascular measurements were performed with a Mobil-O-Graph 24-h PWA Monitor, an automatic oscillometric device. RESULTS: According to the vascular function parameters of patients with active and inactive BD, 24-h, day, and night PWV values were higher in patients with active BD than in patients with inactive BD (p < 0.05). When we performed a linear regression analysis, 24-h PWV was positively correlated with age and duration of BD. Cardiac output (CO) values and day central diastolic blood pressure (DBP) were higher in patients with BD than in the control group (p < 0.05). CONCLUSIONS: PWV values were higher in patients with active BD than in patients with inactive BD. This may be explained by more prominent inflammatory changes in the vascular wall in the active disease period. Further studies in large populations are required to confirm our results.


Asunto(s)
Síndrome de Behçet/fisiopatología , Presión Sanguínea/fisiología , Arteria Braquial/fisiopatología , Resistencia Vascular/fisiología , Rigidez Vascular/fisiología , Adolescente , Adulto , Gasto Cardíaco/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...